• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D3 合成失调会导致胆管癌生长加剧。

Dysregulation of vitamin D3 synthesis leads to enhanced cholangiocarcinoma growth.

机构信息

Scott & White Digestive Disease Research Center, Scott & White, Texas A&M Health Science Center, College of Medicine, Temple, TX, USA.

出版信息

Dig Liver Dis. 2013 Apr;45(4):316-22. doi: 10.1016/j.dld.2012.12.012. Epub 2013 Feb 1.

DOI:10.1016/j.dld.2012.12.012
PMID:23375797
Abstract

BACKGROUND

Cholangiocarcinoma is a deadly biliary tumour with limited treatment strategies. Vitamin (1,25(OH)2D) has anti-proliferative effects on several cancers. Vitamin D3 is synthesized by the enzyme, CYP27B1, and signals via the nuclear vitamin D3 receptor. The enzyme, CYP24A1, degrades vitamin D3.

AIMS

(i) Measure the expression of CYP27B1, CYP24A1, and vitamin D3 receptor in human nonmalignant and cholangiocarcinoma lines and biopsy control or tumour samples; and (ii) evaluate the effects of vitamin D3 on vitamin D3 synthesis and cholangiocarcinoma growth.

METHODS

In vitro studies were performed in malignant and nonmalignant cholangiocytes. Vitamin D3 receptor, CYP24 and CYP27 expression was measured in cell lines and biopsy samples. Cell lines were stimulated with vehicle or vitamin D3 from 30min to 48h. Cell viability was assessed by MTS assays and BrdU incorporation. Vitamin D3 receptor, CYP24A1 and CYP27B1 expression was measured in cholangiocarcinoma cells stimulated with vehicle or vitamin D3.

RESULTS

In cholangiocarcinoma lines and biopsy samples, vitamin D3 receptor and CYP24A1 expression increased compared to controls, whereas CYP27B1 expression was decreased or unchanged. Vitamin D3 induced nuclear translocation of vitamin D3 receptor in cholangiocarcinoma and decreased cholangiocarcinoma growth.

CONCLUSION

Treatment with vitamin D3 decreased CYP24A1, whereas CYP27B1 expression increased. Modulation of vitamin D3 synthesis may be important in the management of cholangiocarcinoma.

摘要

背景

胆管癌是一种致命的胆道肿瘤,治疗策略有限。维生素(1,25(OH)2D)对多种癌症具有抗增殖作用。维生素 D3 由酶 CYP27B1 合成,并通过核维生素 D3 受体发出信号。酶 CYP24A1 降解维生素 D3。

目的

(i)测量人非恶性和胆管癌细胞系和活检对照或肿瘤样本中 CYP27B1、CYP24A1 和维生素 D3 受体的表达;(ii)评估维生素 D3 对维生素 D3 合成和胆管癌生长的影响。

方法

在恶性和非恶性胆管细胞中进行体外研究。在细胞系和活检样本中测量维生素 D3 受体、CYP24 和 CYP27 的表达。细胞系用载体或维生素 D3 刺激 30 分钟至 48 小时。通过 MTS 测定和 BrdU 掺入评估细胞活力。用载体或维生素 D3 刺激胆管癌细胞后测量维生素 D3 受体、CYP24A1 和 CYP27B1 的表达。

结果

与对照相比,胆管癌细胞系和活检样本中的维生素 D3 受体和 CYP24A1 表达增加,而 CYP27B1 表达减少或不变。维生素 D3 诱导胆管癌细胞中维生素 D3 受体的核易位,并降低胆管癌细胞的生长。

结论

维生素 D3 的治疗降低了 CYP24A1 的表达,而 CYP27B1 的表达增加。维生素 D3 合成的调节可能在胆管癌的治疗中很重要。

相似文献

1
Dysregulation of vitamin D3 synthesis leads to enhanced cholangiocarcinoma growth.维生素 D3 合成失调会导致胆管癌生长加剧。
Dig Liver Dis. 2013 Apr;45(4):316-22. doi: 10.1016/j.dld.2012.12.012. Epub 2013 Feb 1.
2
Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).人结肠癌细胞中25-羟维生素D(3)-1α-羟化酶、25-羟维生素D(3)-24-羟化酶及维生素D受体表达的克隆差异:表皮生长因子和1α,25-二羟维生素D(3)的作用
Exp Cell Res. 2002 Jun 10;276(2):320-7. doi: 10.1006/excr.2002.5528.
3
Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma.维生素 D 羟化酶 CYP2R1、CYP27B1 和 CYP24A1 在肾细胞癌中的作用。
Eur J Clin Invest. 2013 Dec;43(12):1282-90. doi: 10.1111/eci.12176. Epub 2013 Oct 12.
4
Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol.人多形性胶质母细胞瘤中的维生素D(3)代谢:CYP27B1剪接变体的功能、骨化二醇的代谢及骨化三醇的作用
Clin Cancer Res. 2005 Aug 1;11(15):5370-80. doi: 10.1158/1078-0432.CCR-04-1968.
5
Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.1α,25-二羟维生素 D3 治疗后小鼠组织中维生素 D 受体靶基因、钙和 PTH 水平的时间变化。
Am J Physiol Endocrinol Metab. 2013 May 1;304(9):E977-89. doi: 10.1152/ajpendo.00489.2012. Epub 2013 Mar 12.
6
Regulation of Vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts.1,25-二羟维生素D3和环磷酸腺苷对培养的人合体滋养层细胞中维生素D羟化酶基因表达的调控
J Steroid Biochem Mol Biol. 2007 Jan;103(1):90-6. doi: 10.1016/j.jsbmb.2006.07.010. Epub 2006 Oct 31.
7
Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.25-羟基维生素 D3 在人前列腺细胞中的抗增殖活性。
Mol Cell Endocrinol. 2014 Feb 15;382(2):960-70. doi: 10.1016/j.mce.2013.11.014. Epub 2013 Nov 27.
8
Kinetic studies of 25-hydroxy-19-nor-vitamin D3 and 1 alpha,25-dihydroxy-19-nor-vitamin D3 hydroxylation by CYP27B1 and CYP24A1.CYP27B1和CYP24A1对25-羟基-19-去甲维生素D3和1α,25-二羟基-19-去甲维生素D3羟基化作用的动力学研究。
Drug Metab Dispos. 2007 Sep;35(9):1482-8. doi: 10.1124/dmd.107.015602. Epub 2007 Jun 6.
9
Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D(3) in human prostate cells.25-羟基-19-去甲维生素 D(3)在人前列腺细胞中的抗增殖作用机制。
J Mol Endocrinol. 2011 Aug 31;47(2):209-18. doi: 10.1530/JME-11-0008. Print 2011 Oct.
10
Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.25-羟维生素D-24-羟化酶(Cyp24a1)基因敲除小鼠血液和组织中1α,25-二羟维生素D3和25-羟维生素D3的药代动力学改变
Endocrinology. 2005 Feb;146(2):825-34. doi: 10.1210/en.2004-1116. Epub 2004 Oct 21.

引用本文的文献

1
Serum 25-Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY Trial.晚期胆管癌患者血清25-羟维生素D水平与生存结局:NIFTY试验结果
Cancer Med. 2025 Jan;14(1):e70560. doi: 10.1002/cam4.70560.
2
The Constellation of Risk Factors and Paraneoplastic Syndromes in Cholangiocarcinoma: Integrating the Endocrine Panel Amid Tumour-Related Biology (A Narrative Review).胆管癌中的危险因素与副肿瘤综合征组合:结合肿瘤相关生物学中的内分泌指标(一篇叙述性综述)
Biology (Basel). 2024 Aug 26;13(9):662. doi: 10.3390/biology13090662.
3
Hepatic Nuclear Receptors in Cholestasis-to-Cholangiocarcinoma Pathology.
胆汁淤积至胆管癌病理过程中的肝脏核受体
Am J Pathol. 2025 Mar;195(3):409-421. doi: 10.1016/j.ajpath.2024.07.023. Epub 2024 Sep 24.
4
Vitamin D in liver cancer: novel insights and future perspectives.肝癌中的维生素 D:新的见解和未来展望。
Croat Med J. 2022 Apr 30;63(2):187-196. doi: 10.3325/cmj.2022.63.187.
5
Vitamin D and Gastrointestinal Cancers: A Narrative Review.维生素 D 与胃肠道癌症:一篇叙述性综述。
Dig Dis Sci. 2019 May;64(5):1098-1109. doi: 10.1007/s10620-018-5400-1. Epub 2018 Dec 3.
6
Diagnostic and prognostic serum marker of cholangiocarcinoma (Review).胆管癌的诊断和预后血清标志物(综述)
Oncol Lett. 2015 Jan;9(1):3-8. doi: 10.3892/ol.2014.2696. Epub 2014 Nov 10.
7
Vitamin D and GI cancers: shedding some light on dark diseases.维生素 D 与胃肠道癌症:揭示这些隐匿性疾病。
Ann Transl Med. 2014 Jan;2(1):9. doi: 10.3978/j.issn.2305-5839.2013.03.04.
8
Chemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model.在化学诱导的动物模型中,膳食补充维生素D对胆管癌的化学预防和化疗作用。
Oncotarget. 2014 Jun 15;5(11):3849-61. doi: 10.18632/oncotarget.2000.